Navigation Links
Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit
Date:8/11/2008

WALTHAM, Mass., Aug. 11 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, announced today that it has received licensure from the United States Department of Agriculture (USDA) to manufacture, market and distribute the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit. Test results are available in 15 minutes compared to traditional methods, which can take days to produce results.

Responding to a USDA-identified need for a rapid influenza test for veterinary use, Inverness sought and has now obtained USDA clearance for testing in avian species. Inverness is the only manufacturer to have two versions of their rapid antigen test kit for influenza: one USDA licensed for veterinary use and the other FDA cleared for human use.

The BinaxNOW AI Antigen Test is an easy-to-use, rapid immunochromatographic test (ICT) that detects influenza A nucleoproteins in chicken, turkey and duck samples. No specialized equipment or training is necessary. Use of the BinaxNOW AI test enables early and accurate identification of influenza A nucleoproteins, facilitating the implementation of appropriate and cost-effective action plans.

Worldwide, many strains of avian influenza virus (AIV) can cause varying degrees of disease in poultry. Some strains are extremely infectious and a fatal form of the disease can spread rapidly from flock to flock. The prominent subtypes of avian influenza viruses include H5 and H7. The BinaxNOW AI Antigen Test is capable of detecting all subtypes, including H5 and H7.

Effective and timely detection of AIV is not only important for the protection of animals and our food supply, but infections with these viruses can occur in humans. According to the CDC, the risk to humans from avian influenza is generally low. However, confirmed cases of human infection from several subtypes of avian influenza infection have been reported since 1997. Thus, early identification and effective management of infected animals may have important benefits for human health worldwide.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com .

This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements regarding the potential benefits of the new product. These statements reflect Inverness' current views with respect to future events and are based on its management's current assumptions and information currently available. Actual results may differ materially due to numerous factors including, without limitation, risks associated with market acceptance of the product; Inverness' ability to successfully manufacture and distribute the product; Inverness ability to secure and maintain the regulatory approvals or clearances necessary to sell the product in various markets; and the risks and uncertainties described in Inverness' annual report on Form 10-K, and other factors identified from time to time in its periodic filings with the Securities and Exchange Commission. Inverness undertakes no obligation to update any forward-looking statements contained herein.


'/>"/>
SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
2. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
3. First Ever Study on Alzheimers Disease Treatment in Hispanics Presented at Major Medical Meeting
4. Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market
5. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
6. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
7. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
8. Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms
9. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
10. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
11. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), ... a company overview at the BMO Capital Markets Prescriptions for Success ... NY . A live webcast of the presentation ... Ionis website.  The replay will be available within 48 hours and ... ...
(Date:12/7/2016)... (NYSE: LCI ) today announced that the company will ... Conference on December 14, 2016 at 9:20 a.m. (ET) at the ... In addition, the company will host one-on-one meetings with ... Boston Healthcare Conference taking place on December 13, 2016 at the ... , , ...
(Date:12/6/2016)... -- Alopexx Oncology, LLC announced data from a Phase I ... composed of interleukin-2 and a CD20-targeting monoclonal antibody. The ... as Rituxan and maintains the activities of both the ... tumor targeting, engagement of the immune system, and induction ... study (abstract #95954) were presented at the 58 th ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, ... families throughout the Five Boroughs, is launching a charity drive to raise funds that ... the traditions and spirit of marines and Navy FMF Corpsmen. Working closely with the ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... December 07, 2016 , ... The medical profession is well aware that heart ... major study analyzing heart attacks among 138,602 people recorded a 35% higher number of ... would all agree of course–no time of year is a good time for a ...
(Date:12/7/2016)... Norwalk, CT (PRWEB) , ... December 07, 2016 ... ... the Integrated Infertility and Wellness (IFW) Program at Reproductive Medicine Associates of Connecticut ... which now has a team of three acupuncturists to help patients realize their ...
Breaking Medicine News(10 mins):